(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

XESTHERAPY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

XESTHERAPY

ST13

US500000079215702

Classe

41, 44

Pedido

79215702

Registro

5477908

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

33

Atualização mais recente

20/02/2026

Tipo de marca

Verbal

Classes Nice

41, 44

Data de depósito

28/06/2017

Data de registro

29/05/2018

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/12/2024

Última transação

20/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

01

Localização do titular

KR

Examinador

EVANKO, PATRICIA MALESARDI

Unidade examinadora

N10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

KIM, Beom Young

Representantes

Park, Min-Heung

Classificação técnica

Classes Nice

Classe 41Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 41

Providing educational courses in the field of health care; instruction in the field of meditation therapy for health care; instruction in the field of health care teaching; publication of textsbooksmagazines and other printed matter; arranging and conducting of seminars in the fields of psychology for educational purposes; event agency services relating to medicine for educational purposesholding an exhibition services for educational events relating to medicine; consultancy relating to education instruction; conducting instructional courses for mind training; consultancy services relating to meditation education; research in the field of education pertaining to educational instruction in the field of meditation; publication of books and magazine; publication of books; meditation training services relating to physical health; research in the field of education pertaining to educational instruction in the field of psychological counseling; educational consultancy servicesconsulting services relating to educational courses in the field of psychological counseling; psychic consultancy academiesproviding schools featuring classes in the field of psychic consultancy; sports instruction for psychotherapy; medical education services namelyconducting classes and seminars in the field of medicine; organization of seminarsworking groupsresearch groups and conventions for educational purposesin the field of medicine

Classe 44

medical and health care services relating to DNAgenetics and genetic testing; advisory services relating to health care; consultancy services relating to health care; health care; managed health care services; health counseling; provision of health information; health clinic services; play therapy services; psychological counselling therapy; psychological and lifestyle counselling; psychological assessment services; psychological health care services; psychological counselling of staff; psychological consultation; provision of psychological advice; psychological therapy; provision of psychological treatment; music therapy services; stress management services for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

33 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

19/02/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

01/02/2026

INPC

INVALIDATION PROCESSED

01/02/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

13/08/2025

C71T

CANCELLED SECTION 71

13/12/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/02/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/02/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/10/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

14/09/2018

FIMP

FINAL DISPOSITION PROCESSED

14/09/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/08/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

29/05/2018

PUBO

PUBLISHED FOR OPPOSITION

13/03/2018

NPUB

NOTICE OF PUBLICATION

21/02/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/02/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2018

DOCK

ASSIGNED TO EXAMINER

01/02/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/01/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

12/12/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/11/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/11/2017

ALIE

ASSIGNED TO LIE

08/11/2017

RFNT

REFUSAL PROCESSED BY IB

04/11/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/10/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/10/2017

RFRR

REFUSAL PROCESSED BY MPU

16/10/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/10/2017

CNRT

NON-FINAL ACTION WRITTEN

11/10/2017

DOCK

ASSIGNED TO EXAMINER

25/09/2017

MAFR

APPLICATION FILING RECEIPT MAILED

12/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/09/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/09/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace XESTHERAPY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.